Belén Garijo, Merck KGaA CEO (via Merck KGaA)

Mer­ck KGaA con­tin­ues ex­pan­sion with $285M+ in­vest­ment in 2 new projects in France and Ger­many

It is no se­cret that Mer­ck KGaA has been on an ex­pan­sion dri­ve across the US and Ire­land over the past year, but its lat­est move will look to boost the com­pa­ny’s pres­ence in main­land Eu­rope too.

The com­pa­ny is look­ing to in­vest around €130 mil­lion ($129 mil­lion) in­to sin­gle-use as­sem­blies as part of the pro­duc­tion of Covid-19 vac­cines and oth­er ther­a­peu­tics at its site in Mol­sheim, France, a city in the east of the coun­try. The in­vest­ment in the 50-year-old site will al­so aim to cre­ate around 800 jobs by 2028.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.